Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses

References

• Akbari M, Oryan A, Hatam G. Application of nanotechnology in treatment of leishmaniasis: a review. Acta Trop. 2017;172:86–90.
   PubMed Web of Science ®Google Scholar
• Van Bocxlaer K, Yardley V, Murdan S, et al. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model. J Pharm Pharmacol. 2016;68(7):862–872.
   PubMed Web of Science ®Google Scholar
• Bruni N, Stella B, Giraudo L, et al. Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomed. 2017;12:5289–5311.
   PubMed Web of Science ®Google Scholar
• Gutiérrez V, Seabra AB, Reguera RM, et al. New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev. 2016;45(1):152–168.
   PubMed Web of Science ®Google Scholar
• Sundar S, Chakravarty J, Meena LP. Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opin Orphan Drugs. 2019;7(1):1–10.
   Web of Science ®Google Scholar
• Das S, Khan W, Mohsin S, et al. Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation. Polym Adv Technol. 2011;22(1):172–179.
   Web of Science ®Google Scholar
• Sundar S, Chakravarty J. Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother. 2013;14(1):53–63.
   PubMed Web of Science ®Google Scholar
• Machado PR, Ampuero J, Guimarães LH, et al. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis. 2010;4(12):e912.
   PubMed Web of Science ®Google Scholar
• Mohebali M, Fotouhi A, Hooshmand B, et al. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop. 2007;103(1):33–40.
   PubMed Web of Science ®Google Scholar
• Soto J, Toledo J, Valda L, et al. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis. 2007;44(3):350–356.
   PubMed Web of Science ®Google Scholar
• Chakravarty J, Sundar S. Current and emerging medications for the treatment of leishmaniasis. Expert Opin Pharmacother. 2019;20(10):1251–1265.
   PubMed Web of Science ®Google Scholar
• Dorlo TP, Balasegaram M, Beijnen JH, et al. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother. 2012;67(11):2576–2597.
   PubMed Web of Science ®Google Scholar
• Dar MJ, McElroy CA, Khan MI, et al. Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Deliv. 2020;17(1):97–110.
   PubMed Web of Science ®Google Scholar
• Sundar S, Olliaro PL. Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther Clin Risk Manag. 2007;3(5):733–740.
   PubMedGoogle Scholar
• WHO. Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases. Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases; 2010 Mar 22–26; Geneva.
   Google Scholar
• Dar MJ, Din FU, Khan GM. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Deliv. 2018;25(1):1595–1606.
   PubMed Web of Science ®Google Scholar
• Moreno E, Schwartz J, Fernández C, et al. Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Deliv. 2014;11(4):579–597.
   PubMed Web of Science ®Google Scholar
• Nylén S, Eidsmo L. Tissue damage and immunity in cutaneous leishmaniasis. Parasite Immunol. 2012;34(12):551–561.
   PubMed Web of Science ®Google Scholar
• Oshima S, Suzuki C, Yajima R, et al. The use of an artificial skin model to study transdermal absorption of drugs in inflamed skin. Biol Pharm Bull. 2012;35(2):203–209.
   PubMed Web of Science ®Google Scholar
• Hughes JP, Rees S, Kalindjian SB, et al. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239–1249.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104(1):226–232.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers. Transfersomes. Biochim Biophysi Act Biomembr. 2001;1514(2):191–205.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, et al. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2007;332(1-2):1–16.
   PubMed Web of Science ®Google Scholar
• Rabia S, Khaleeq N, Batool S, et al. Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route. Nanomedicine). 2020;15(2):183–203.
   PubMed Web of Science ®Google Scholar
• Salim MW, Shabbir K, Yousaf AM, et al. Preparation, in-vitro and in-vivo evaluation of rifampicin and vancomycin co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis. J Drug Deliv Sci Technol. 2020;60:101996.
   Web of Science ®Google Scholar
• Zeb A, Arif ST, Malik M, et al. Potential of nanoparticulate carriers for improved drug delivery via skin. J Pharm Investig. 2019;49(5):485–517.
   Google Scholar
• Kumar A, Pathak K, Bali V. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today. 2012;17(21-22):1233–1241.
   PubMed Web of Science ®Google Scholar
• Barry BW. Breaching the skin's barrier to drugs. Nat Biotechnol. 2004;22(2):165–167.
   PubMed Web of Science ®Google Scholar
• Bouwstra J, Honeywell-Nguyen P. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 2002;54:S41–S55.
   PubMed Web of Science ®Google Scholar
• Silva SM, Sousa JJ, Marques EF, et al. Structure activity relationships in alkylammonium C12-gemini surfactants used as dermal permeation enhancers. AAPS J. 2013;15(4):1119–1127.
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol. 2005;2(1):67–74.
   PubMedGoogle Scholar
• Khan MA, Pandit J, Sultana Y, et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 2015;22(6):795–802.
   PubMed Web of Science ®Google Scholar
• Zeb A, Qureshi OS, Yu C-H, et al. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int J Pharm. 2017;525(1):92–100.
   PubMed Web of Science ®Google Scholar
• Kalat SM, Khamesipour A, Bavarsad N, et al. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Exp Parasitol. 2014;143:5–10.
   PubMed Web of Science ®Google Scholar
• Bafghi AF, Zadeh HF, Hejazian SH. Leishmania (L) major [MRHO/IR/75/ER] in the Balb/c mice and treatment with natural sweetner as a home remedy. World J Zoo. 2008;3(1):19–24.
   Google Scholar
• Ghanbarzadeh S, Khorrami A, Arami S. Nonionic surfactant-based vesicular system for transdermal drug delivery. Drug Deliv. 2015;22(8):1071–1077.
   PubMed Web of Science ®Google Scholar
• Ahad A, Al-Saleh AA, Al-Mohizea AM, et al. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes carbopol® gel under Dermaroller® on rats with methyl prednisolone acetate-induced hypertension. Biomed Pharmacother. 2017;89:177–184.
   PubMed Web of Science ®Google Scholar
• Din FU, Rashid R, Mustapha O, et al. Development of a novel solid lipid nanoparticles-loaded dual-reverse thermosensitive nanomicelle for intramuscular administration with sustained release and reduced toxicity. RSC Adv. 2015;5(54):43687–43694.
   Web of Science ®Google Scholar
• Khurana RK, Bansal AK, Beg S, et al. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm. 2017;518(1-2):289–306.
   PubMed Web of Science ®Google Scholar
• Din FU, Choi JY, Kim DW, et al. Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration. Drug Deliv. 2017;24(1):502–510.
   PubMed Web of Science ®Google Scholar
• Valenzuela-Oses JK, García MC, Feitosa VA, et al. Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment. Mater Sci Eng C Mater Biol Appl. 2017;81:327–333.
   PubMed Web of Science ®Google Scholar
• Din FU, Zeb A, Shah KU, et al. Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product. J Drug Deliv Sci Technol. 2019;51:583–590.
   Web of Science ®Google Scholar
• Kurakula M, Ahmed OA, Fahmy UA, et al. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res. 2016;26(4):288–296.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397(1-2):164–172.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Mahajan A, et al. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target. 2011;19(4):293–302.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier for transdermal delivery. Int J Pharm. 2013;454(1):367–380.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Goindi S, Mehta SD. Preparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancer. AAPS PharmSciTech. 2012;13(1):67–74.
   PubMed Web of Science ®Google Scholar
• Amin S, Sarfenejad A, Ahmad J, et al. Nanovesicular transfersomes for enhanced systemic delivery of telmisartan. Adv Sci Engng Med. 2013;5(4):299–308.
   Google Scholar
• Qushawy M, Nasr A, Abd-Alhaseeb M, et al. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics. 2018;10(1):26.
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Ramzan M, et al. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv. 2016;23(4):1115–1129.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles. Artif Cells Nanomed Biotechnol. 2016;44(6):1457–1463.
   PubMed Web of Science ®Google Scholar
• Rathod HJ, Mehta DP. A review on pharmaceutical gel. Int J Pharm Sci. 2015;1(1):33–47.
   Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, et al. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011;2011:418316.
   PubMedGoogle Scholar
• Nazari-Vanani R, Vais RD, Sharifi F, et al. Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes. Acta Trop. 2018;185:69–76. Sep
   PubMed Web of Science ®Google Scholar
• Jaafar-Maalej C, Diab R, Andrieu V, et al. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20(3):228–243.
   PubMed Web of Science ®Google Scholar
• Pereira-Camelo SR, Francesch S, Perez E, et al. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug. Drug Dev Indl Pharm. 2016;42(6):985–997.
   PubMed Web of Science ®Google Scholar
• Malakar J, Sen SO, Nayak AK, et al. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J. 2012;20(4):355–363.
   PubMed Web of Science ®Google Scholar
• Tripathi P, Jaiswal AK, Dube A, et al. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani. Inter J Biol Macromol. 2017;105:625–637.
   PubMed Web of Science ®Google Scholar
• Patel HK, Barot BS, Parejiya PB, et al. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies. Colloids Surf B Biointerfaces. 2013;102:86–94.
   PubMed Web of Science ®Google Scholar
• Singh S, Verma D, Mirza MA, et al. Development and optimization of ketoconazole loaded nano-transfersomal gel for vaginal delivery using Box-Behnken design: in vitro, ex vivo characterization and antimicrobial evaluation. J Drug Deliv Sci Technol. 2017;39:95–103.
   Web of Science ®Google Scholar
• Gupta PN, Mishra V, Singh P, et al. Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol. 2005;57(3):295–301.
   PubMed Web of Science ®Google Scholar
• Zeb A, Qureshi OS, Kim HS, et al. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomed. 2016;11:3813–3824.
   PubMed Web of Science ®Google Scholar
• Cao M, Ren L, Chen G. Formulation optimization and ex vivo and in vivo evaluation of celecoxib microemulsion-based gel for transdermal delivery. AAPS PharmSciTech. 2017;18(6):1960–1971.
   PubMed Web of Science ®Google Scholar
• Najafian HR, Mohebali M, Rezayat SM, et al. Nanoliposomal miltefosine for the treatment of cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): the drug preparation and in vitro study. Int J Pharm Res Allied Sci. 2016;5(3):97–107.
   Web of Science ®Google Scholar
• Guimaraes ET, Lima MS, Santos LA, et al. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis. J Antimicrob Chemother. 2009;64(1):84–87.
   PubMed Web of Science ®Google Scholar
• Rosas LE, Keiser T, Barbi J, et al. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int Immunol. 2005;17(10):1347–1357.
   PubMed Web of Science ®Google Scholar
• Guimarães ET, Santos LA, dos Santos RR, et al. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice. Microbes Infect. 2006;8(5):1219–1226.
   PubMed Web of Science ®Google Scholar
• Szoka F, Jr., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA. 1978;75(9):4194–4198.
   PubMed Web of Science ®Google Scholar
• Avadhani KS, Manikkath J, Tiwari M, et al. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv. 2017;24(1):61–74.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Goindi S. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-dermatophytosis. Int J Pharm. 2012;437(1-2):277–287.
   PubMed Web of Science ®Google Scholar
• Din FU, Mustapha O, Kim DW, et al. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur J Pharm Biopharm. 2015;94:64–72.
   PubMed Web of Science ®Google Scholar
• Maeki M, Fujishima Y, Sato Y, et al. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. PLoS One. 2017;12(11):e0187962.
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, et al. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258(1-2):141–151.
   PubMed Web of Science ®Google Scholar
• Khaleeq N, Din F-U, Khan AS, et al. Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product. J Microencapsul. 2020;37(2):160–169.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Eum JY, Jeong MS, et al. Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol Pharm Bull. 2010;33(1):100–106.
   PubMed Web of Science ®Google Scholar
• Kaur L, Jain SK, Singh K. Vitamin E TPGS based nanogel for the skin targeting of high molecular weight anti-fungal drug: development and in vitro and in vivo assessment [10.1039/C5RA08374E. RSC Adv. 2015;5(66):53671–53686.
   Web of Science ®Google Scholar
• Raquel F-G, Larry S, Jéssica A. d J, et al. Ultradeformable lipid vesicles localize Amphotericin B in the dermis for the treatment of infectious skin diseases. ACS Infect. Dis. 2020;6:2647–2660.
   PubMed Web of Science ®Google Scholar
• Ascenso A, Salgado A, Euletério C, et al. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles. Eur J Pharm Biopharm. 2014;88(1):48–55.
   PubMed Web of Science ®Google Scholar
• Borborema SET, Schwendener RA, Osso JA, et al. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages. Int J Antimicrob Agents. 2011;38(4):341–347.
   PubMed Web of Science ®Google Scholar
• Khan AS, Ud Din F, Ali Z, et al. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous leishmaniasis. Int. J. Pharm. 2021;593:120109.DOI:10.1016/j.ijpharm.2020.120109
   PubMedGoogle Scholar
• Nan A, Croft SL, Yardley V, et al. Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis. J Control Release. 2004;94(1):115–127.
   PubMed Web of Science ®Google Scholar
• Layoun A, Samba M, Santos MM. Isolation of murine peritoneal macrophages to carry out gene expression analysis upon toll-like receptors stimulation. J Vis Exp. 2015;98:e52749.
   PubMed Web of Science ®Google Scholar
• Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5(11):941–955.
   PubMed Web of Science ®Google Scholar
• Zeb A, Rana I, Choi HI, et al. Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals. Pharmaceutics. 2020;12(12):1184.
   Web of Science ®Google Scholar